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A dileucine motif in HIV-1 Nef is essential for sorting into
clathrin-coated pits and for downregulation of CD4
Michael Greenberg*, Louis DeTulleo†‡, Iris Rapoport‡, Jacek Skowronski* 
and Tomas Kirchhausen‡
Nef, a ~200 residue multifunctional regulatory protein
of human immunodeficiency virus (HIV) and simian
immunodeficiency virus (SIV), interacts with
components of host cell signal transduction and
clathrin-dependent protein sorting pathways. The
downregulation of surface CD4 molecules and major
histocompatibility complex (MHC) class I antigens by
Nef is believed to be important in AIDS pathogenesis
[1–7]. Nef contains a globular core domain and two
disordered segments — a myristylated arm at the amino
terminus and a carboxy-terminal loop projecting from
the globular core [8,9]. Here, we aimed to determine the
sorting signals in HIV-1 Nef that were responsible for
its involvement in the clathrin-mediated pathway. We
found that a sequence in the carboxy-terminal
disordered loop of Nef is essential for downregulation
of CD4. This sequence resembles the dileucine motif,
one of two well-characterized sorting signals that
target membrane proteins to clathrin-coated vesicles.
The dileucine-motif-containing segment of Nef bound
directly and specifically to the b-adaptin subunit of the
clathrin adaptor complexes AP-1 and AP-2, which are
responsible for recruiting sorted proteins into coated
pits. Unlike wild-type Nef, a mutant form of Nef that
lacked the dileucine motif did not localize to clathrin-
coated pits and did not downregulate CD4 expression,
although it could downregulate MHC class I surface
expression. Thus, the dileucine motif in HIV-1 is
required for CD4 downregulation and for interaction
with clathrin adaptor complexes.
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Results and discussion
Mutations in short sequences in the two disordered loops
of HIV-1 Nef prevent localization of Nef to coated pits
and CD4 downregulation, but these sequences do not cor-
respond to canonical sorting signals [10]. It has been
claimed that Nef interacts with adaptor proteins through a
tyrosine-based motif of the type YppØ (where Y is tyro-
sine, p is a polar residue and Ø is a bulky hydrophobic
amino acid) in the amino-terminal arm, but the two YppØ
motifs identified in that study (which was performed on
SIV mac239 Nef) are absent in Nef proteins from HIV-1
strains (although similar tyrosine-based sequences are
present in HIV-2 Nef) [11]. Therefore, this motif is proba-
bly not the essential targeting motif directing Nef traffic,
although it may have an auxiliary role. 
As many of the proteins that traffic via clathrin-dependent
pathways contain either dileucine or YppØ motifs [12], we
examined the primary structures of HIV-1 Nef for candi-
date sorting signals. Although there were no conserved
YppØ motifs, a conserved dileucine sequence surrounded
by polar residues was identified in an otherwise variable
region of the protein located in the carboxy-terminal disor-
dered loop (see Supplementary material published with
this paper on the internet). A similar sequence (LM or
LV) is found at the corresponding position in HIV-2 and
SIV Nef. The dileucine sorting signal not only requires a
leucine doublet, but also requires polar surrounding
sequences [13], presumably causing the dileucine
sequence to be exposed on the surface of the protein. A
glutamic acid residue is always present at position –4 rela-
tive to the first leucine of the leucine doublet. This
sequence in Nef thus has all the characteristics of a
dileucine sorting signal. We therefore investigated
whether a peptide containing this sequence could interact
directly with adaptor protein complexes.
To determine whether the dileucine-containing region con-
tains an active sorting dileucine motif, we used a crosslink-
ing protocol in which peptides and adaptor proteins were
first frozen, and then subjected to crosslinking in the frozen
state, a condition that does not affect the specificity of inter-
actions between the adaptor protein and peptide [13,14].
Using this method, peptides bearing a dileucine sorting
signal were found to bind specifically to the β1-adaptin
subunit of AP-1 [13]. Those experiments were performed
in the presence of detergent, however, and the interactions
with the β-adaptin subunits of AP-2 were too weak to
detect under such conditions. Repeating the experiments in
the absence of detergent led to the interaction with AP-1
becoming stronger and the interactions with the β1-adaptin
and β2-adaptin subunits of AP-2 being readily detectable.
The specificity of the interaction can be examined by using
the test peptides as competitors for a biotinylated dileucine-
motif-containing peptide derived from the γ subunit of the
T-cell receptor that also contains the UV-activatable
crosslinker benzoyl phenylalanine (*CD3γ-LL; Figure 1,
lane 1). The Nef-derived peptide EEANTGENNSLLH-
PMS from HIV-1 NA7 (Nef-LL) [4], like other peptides
containing active dileucine motifs [13], specifically blocked
the interaction between *CD3γ-LL and the ~100 kDa 
β-adaptin subunits of AP-1 and AP-2 (Figure 1, lanes 3–6).
In contrast, a mutant Nef peptide in which the two leucine
residues (L164L165) were replaced by alanine residues 
(Nef-AA) did not bind to β1-adaptin or β2-adaptin (Figure
1, lane 2). The apparent inhibition constants (IC50s), corre-
sponding to the amount of peptide required to inhibit the
crosslinking reaction by 50%, probably indicate that the
interactions with AP-2 are weaker than with AP-1; the
absolute IC50 values cannot be determined with confidence
because the concentrations of peptide and adaptor proteins
in areas of the frozen solution are higher relative to those in
the liquid solution [13]. Thus, the clathrin adaptor proteins
specifically recognize the dileucine motif found in Nef.
This result is consistent with the association between
GST–Nef and AP-1 detected in vitro [15]. 
We next asked whether Nef mutants that lack the dileucine
motif retain the ability to localize with AP-1 and AP-2 adap-
tors in clathrin-coated pits. As previously shown [10], the
HIV-1 NA7 Nef protein tagged with green fluorescent
protein (GFP), Nef-LL–GFP, co-localized with adaptors in
clathrin-coated pits at the plasma membrane (Figure 2d–f)
and in the trans-Golgi network (TGN; Figure 2m–o). We
constructed a mutant Nef–GFP fusion protein in which 
the two leucine residues were replaced with alanines 
(Nef-AA–GFP) and expressed it in rat REF52 and in
human IMR90 fibroblasts by transient transfection. The
Nef-AA–GFP mutant retains the myristylation sequence,
and should be targeted normally to intracellular mem-
branes. This mutant failed to localize with AP-2 adaptors
(α-adaptin staining) at the cell surface (Figure 2g–i). We
can rule out the possibility that the failure to localize with
AP-2 is due to gross misfolding of the Nef-AA–GFP protein
because this mutant has the same ability to downregulate
MHC class I as the wild-type Nef-LL–GFP fusion protein
(see below). The perinuclear localization for Nef-LL–GFP
(Figure 2m–o) and Nef-AA–GFP (Figure 2p–r) was similar
in appearance and overlapped the tight distribution of AP-1
adaptors (γ-adaptin staining) at the TGN. It should be
noted, however, that the resolution of the images does not
allow us to establish with certainty whether the overlap of
the Nef–GFP proteins with AP-1 is specific for coated pits
at the TGN. We conclude that the dileucine motif is
essential for Nef targeting to clathrin-coated pits contain-
ing AP-2 at the plasma membrane. 
To determine whether the dileucine motif is important 
for Nef’s biological function, we examined whether the 
Nef-AA mutant would still downregulate CD4. As previ-
ously described [16], CD4+ Jurkat T cells transiently
transfected with wild-type HIV-1 NA7 Nef downregu-
lated CD4 from the cell surface (Figure 3b,e); this effect
was also observed using HIV-1 NL4-3 Nef fused to GFP
(data not shown) [10]. The Nef-AA mutant derived from
either of these strains had no detectable effect on surface
CD4 levels, however (Figure 3c,f and data not shown). As
indicated by the comparative dose–response experiments
illustrated in Figure 3g, Nef-LL facilitated the downregu-
lation of CD4 over a wide range of Nef expression levels
whereas the Nef-AA mutant did not. However, the
LL→AA mutation did not affect the ability of Nef to
downregulate MHC class I (compare Figure 3b,c with
Figure 3e,f). Thus, the dileucine signal is required both
for Nef targeting to coated pits and for CD4 downregula-
tion, but not for MHC class I downregulation.
Our results show that the interaction of Nef with clathrin
adaptor complexes and the Nef-stimulated downregulation
of CD4 both depend on a dileucine motif in the carboxy-
terminal disordered loop of Nef. The Nef internalization
motif identified in this study is highly conserved in HIV-1,
but it is not the only sequence involved in Nef traffic and
CD4 internalization [10,17]. The dileucine motif is present
in a modified form (LM or LV) in HIV-2 and SIV (see 
Supplementary material). Whether these amino acids also
influence Nef’s effect on CD4 is now under investigation. 
Nef also interacts with the 56 kDa subunit of the vacuolar
membrane ATPase complex (V-ATPase) [17]. The region
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Figure 1
Specific interaction of the dileucine-based motif of HIV-1 NA7 Nef with
the β-adaptin chains of clathrin adaptors. Analysis of the crosslinking of
the UV-photoactive peptide *CD3γ-LL (0.2 µM) with adaptor proteins in
the absence (lane 1) and presence of the competing peptides
EEANTGENNSAAHPMS (Nef-AA; lane 2) and EEANTGENNSLLHPMS
(Nef-LL; lanes 3–6) derived from the disordered loop of HIV-1 NA7 Nef.
*CD3γ-LL is known to associate specifically with the β-adaptin subunits
of AP-1 and AP-2 [13]. The data were obtained using ~0.2 mg/ml AP-1
(upper panel) or AP-2 (lower panel) purified from calf brain coated
vesicles. AP-1 contains β1-adaptin chains, whereas AP-2 has mostly 
β2-adaptin chains and some β1-adaptin chains [21]. 
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required for this interaction was mapped to E178D179 in
HIV-1 SF2 Nef (equivalent to D174D175 in HIV-1 NL4-3
Nef) at the carboxy-terminal boundary between the disor-
dered loop and the core domain. A D174D175→AA HIV-1
NA7 Nef mutant did not localize to clathrin-coated pits
[18] or downregulate CD4 [16,17]. The counterintuitive
finding that both the D174D175→AA and the L164L165→AA
Nef mutants affect CD4 but not MHC class I downregula-
tion indicates that the simple model in which Nef interacts
(directly or indirectly) with CD4 and MHC class I and
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The dileucine motif of Nef is required for the colocalization of Nef and
clathrin adaptor complexes. (a–i) REF52 rat fibroblasts or (j–r) IMR90
human fibroblasts transiently expressing (a–c, j–l) GFP, (d–f, m–o)
Nef-LL–GFP, or (g–i, p–r) Nef-AA–GFP derived from HIV-1 NA7 Nef
were fixed and processed for immunofluorescence. The localization of
clathrin-coated pits containing AP-2 was determined in REF52 cells
using a rabbit polyclonal antibody specific for the α-adaptin subunits of
clathrin adaptor complex AP-2. The localization of clathrin-coated pits
containing AP-1 was determined in IMR90 cells using the mouse
monoclonal antibody 100/3 specific for the γ-adaptin subunit of the
non-rodent clathrin adaptor AP-1, and Texas Red conjugated goat 
anti-rabbit or goat anti-mouse IgG antibody (red). GFP products were
localized by direct fluorescence (green). The overlay of GFP and 
α-adaptin images shows colocalization of Nef-LL–GFP but not of 
Nef-AA–GFP with AP-2 in coated pits at the plasma membrane. 
Figure 3
The effect of the Nef-AA mutant on the
expression of CD4 and MHC class I on the cell
surface. (a–f) Flow cytometry analysis. CD4+
Jurkat T cells were transiently transfected with
18 µg (a,d) control empty expression vector
DNA (vector) or 18 µg DNA encoding (b,e)
wild-type HIV-1 NA7 Nef (Nef-LL) or (c,f)
mutant Nef (Nef-AA), together with 2 µg
plasmid DNA encoding the surface marker
CD20 for the identification of transfected cells.
Flow cytometry analysis was performed 2 days
after transfection on (a–c) the total population
of cells or (d–f) the cells expressing the CD20
transfection marker. CD4, MHC class I, and
CD20 were detected simultaneously by three-
color flow cytometry. The surface levels of
MHC class I (x-axis) and CD4 (y-axis) were
detected with G46-2.6 monoclonal antibody
labeled with fluorescein and with Leu3
monoclonal antibody labeled with
phycoerythrin, respectively. PerCP-conjugated
Leu16 monoclonal antibody was used to
detect CD20+ cells. (g) Dose–response
analysis for the effect of the Nef-AA mutant on
CD4 surface expression. CD4+ Jurkat T cells
were transfected with increasing amounts of
plasmid DNA encoding wild-type HIV NA7 Nef
(Nef-LL), mutant Nef (Nef-AA) and empty
vector as described for (a–f). Surface
expression of CD4 (y-axis) is shown as the
peak channel number of the CD4 signal.
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recruits them into clathrin-coated pits is not likely to be
correct. Clearly MHC class I downregulation occurs via a
separate mechanism that is not affected by either V-
ATPase binding or interaction with adaptor proteins
[17,18]. It is also surprising that, although both the
D174D175 residues and the dileucine motif are necessary
for the localization of Nef to coated pits, neither of these
two elements is alone sufficient for localization.
The model that emerges from these studies is a complex
one: Nef must contain at least four functional regions
required for its effects on membrane traffic, one responsi-
ble for interacting with V-ATPase [17], the second con-
taining a motif for binding to adaptor protein complexes
(this study), the third providing a direct or indirect interac-
tion with CD4 [10,19,20] and the fourth required for
MHC class I downregulation [3,6,15,18]. From our results
and those of Lu et al. [17], it would appear that Nef
requires both the V-ATPase interaction domain and the
adaptor-protein-binding motif to localize to coated pits
and induce CD4 downregulation. These interactions may
therefore be suitable targets for drug design. 
Material and methods
AP-1 and AP-2 adaptor complexes were purified from calf brain coated
vesicles [13,14] and suspended in AP buffer (100 mM MES, 1 mM
EDTA, 150 mM NaCl, 0.5 mM DTT, pH 7.0). The UV-photoactive
crosslinking reaction and the assay to determine the specific interaction
between dileucine-motif-containing peptides and AP subunits has been
described previously [13,14]. Briefly, purified adaptors (~0.2 mg/ml in
18 µl AP buffer) were mixed with 0.2 µM photoactive peptide *CD3γ-LL
(biotin-KQS (benzoylphenylalanine)ApSDKQTLLPN, where pS denotes
phosphoserine) in the presence or absence of non-modified competing
peptide in a final volume of 22 µl. The mixtures were first frozen by
placing them on top of pulverized dry ice and then exposed to UV light
for 3 min. The identity of the AP subunit crosslinked to the biotinylated
*CD3γ-LL was established by SDS–PAGE, followed by electrotransfer
to nitrocellulose, blotting with streptavidin–HRP and detection by
enhanced chemiluminescence (Amersham) on X-ray film. The interaction
of *CD3γ-LL is specific, as crosslinking to the β-adaptin chains is inhib-
ited by co-incubation with non-modified peptides containing the
dileucine motif of CD3γ (RQSRApSDKQTLLPN), CD4 (RMpSQIKR-
LLSEK), Glut4 (ISAAFRRTpSLLEQEVKPSTEL) and M6PR (VSFHDDS-
DEDLLHI) [13]. Various amounts of the synthetic peptides
EEANKGENTSLLHPMS (for Nef-LL) and EEANKGENTSAAHPMS (for
Nef-AA) of strain NA7 were monitored for their ability to prevent the spe-
cific crosslinking reaction between *CD3γ-LL and the β1/β2 subunits of
AP-1 and AP-2. Plasmid construction, DNA transfections, flow cytome-
try and fluorescent light microscopy analysis were performed as
described previously [10,16,18]. 
Supplementary material
A detailed background section and a figure showing the conservation
of the dileucine motif in Nef proteins is published with this paper on
the internet.
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Supplementary background
Nef is a multifunctional regulatory protein of human
immunodeficiency virus (HIV) and simian immunodefi-
ciency virus (SIV) which interacts with host cell signal
transduction and protein sorting machinery. Nef appears
to be an important determinant of the clinical outcome in
people infected with HIV-1 [S1,S2] and in SIV infected
rhesus macaques [S3]. Downregulation of surface CD4
molecules and of major histocompatibility complex
(MHC) class I are conserved functions of Nef that are
believed to have roles in AIDS pathogenesis [S4–S10].
The normal route for CD4 traffic involves entrapment
into clathrin-coated pits and endocytosis, followed by re-
sorting and return to the plasma membrane [S11]. Three
HIV-1 gene products, Env, Vpu and Nef downregulate
expression of cell-surface CD4, and Nef is a major compo-
nent of this downregulation [S12]. Nef accelerates CD4
internalization, without accelerating recycling to the cell
surface [S13]. As well as causing downregulation of CD4,
Nef also causes the surface downregulation of MHC class
I complexes [S9]. Nef localizes to the internal leaflet of
the plasma membrane [S14], and it is therefore possible
that it may interact directly or indirectly with the cytoplas-
mic tails of CD4 or MHC class I.
Nef is a myristylated cytoplasmic protein of ~200
residues. It can be divided into three regions, a globular
core domain and two disordered segments, one a myristy-
lated arm at the amino terminus, and the other a loop pro-
jecting from the globular core (Figure S1a) [S15,S16]. Nef
is the first non-transmembrane protein located in the
internal side of the plasma membrane that is known to be
sorted in the clathrin-dependent pathway, being able to
localize in clathrin-coated pits even in the absence of
other viral proteins and in the absence of CD4 [S14].
Some evidence has been presented to indicate that CD4
and Nef may directly interact; for example, NMR studies
using peptides from the cytoplasmic tail of CD4 appear to
show a weak association between the membrane-proximal
portion of the CD4 tail and the Nef protein [S17]. There-
fore, one possible model for CD4 downregulation is that
Nef binds directly to CD4 and drags it into clathrin-
coated pits [S14,S18].
Site-directed mutagenesis of cellular proteins that traffic
through the clathrin-dependent pathway has identified
several motifs including the dileucine (LL) and tyrosine-
based (YppØ) sorting signals (where L is leucine, Y is tyro-
sine, p is a polar residue and Ø is a bulky hydrophobic
amino acid), that direct proteins to coated pits (reviewed
in [S19]). The presence of either motif in the cytoplasmic
tail of a target protein is sufficient to direct internalization.
The YppØ and dileucine motifs are directly recognized by
different subunits of the clathrin adaptor complexes (APs)
[S20–S23]. These large heterotetrameric complexes are
responsible for recruiting sorted proteins into coated pits,
and link cargo recruitment to clathrin coat assembly [S19].
AP-1 is primarily responsible for clathrin-mediated traffic
from the trans-Golgi network (TGN), while AP-2 is
responsible for traffic originating from the plasma mem-
brane. AP-1 and AP-2 each contain two large chains (γ and
β1 for AP-1, α and β2 for AP-2), a medium chain (µ1 or µ2)
and a small chain (σ1 or σ2). The µ1/µ2 chain is the
binding site for the YppØ motif [S20–S22], while the
β1/β2 chain is responsible for binding the dileucine motif
([S23] and our unpublished observations). 
Using a pull-down assay, it has recently been shown that
Nef can interact with AP-1, raising the possibility that in
cells Nef can interact directly with clathrin adaptors [S24].
Mutations in short sections in the two disordered loops of
HIV-1 Nef have been shown to prevent localization to
coated pits and CD4 downregulation but the sequences do
not correspond to canonical sorting signals [S14]. It has
been claimed that Nef interacts with APs through a tyro-
sine-based motif of the type YppØ in the amino-terminal
arm, but the two motifs identified in that study (performed
on SIV mac239 Nef) are absent in all HIV-1 strains (though
similar tyrosine-based sequences are present in HIV-2 Nef)
[S25]. This motif is therefore an unlikely candidate for the
essential targeting motif directing Nef traffic, although it
may have an auxiliary role in HIV-2 and SIV Nefs. 
We therefore wished to determine whether other sorting
signals are also present in Nef that might further explain
Nef’s ability to interact with clathrin adaptors and to
traffic via the clathrin-mediated pathway. We found that a
dileucine-containing peptide from the so-called carboxy-
terminal disordered loop of Nef binds to the β chains of
AP-1 and AP-2, as expected for an active dileucine-based
internalization signal. This dileucine motif is highly con-
served in the Nef sequence of HIV-1 strains. Mutation of
this motif prevents Nef localization to clathrin-coated pits,
Supplementary material
and also prevents the downregulation of CD4, but not of
MHC class I molecules.
During the course of this study, it was reported that Nef
also interacts with the 56 kDa subunit of the vacuolar
membrane ATPase complex (V-ATPase) on the basis of
experiments using the yeast two-hybrid system [S26]. The
V-ATPase is required for acidification of endosomal com-
partments and also traffics via the clathrin-dependent
pathway [S27,S28]. The region required for interaction
between Nef and the 56 kDa subunit was mapped to
E178D179 in HIV-2 SF2 (equivalent to D174D175 in HIV-1
NL4-3) at the carboxy-terminal boundary between the
disordered loop and the core domain. A mutant HIV-1
NA7 Nef protein in which the amino acids equivalent to
D174D175 were changed to alanines no longer localized to
clathrin-coated pits [S14] and no longer caused downregu-
lation of CD4 [S14,S26]. Antisense experiments have also
been used to show that a decrease in the amount of the
56 kDa subunit reduces the rate of internalization of a
chimeric protein composed of the ectodomain and trans-
membrane portion of CD8 fused to the Nef sequence
[S26]. These results are consistent with the idea that the
interaction between Nef and the V-ATPase is also
required for the recruitment of Nef to clathrin-coated pits,
and hence for CD4 downregulation. The downregulation
of MHC class I molecules is not affected by this mutation,
however [S29].
How does Nef induce the downregulation of MHC class I?
At least three regions of Nef appear to be important in this
process, an acidic motif in the amino-terminal arm, an Src
homology 3 (SH3) ligand domain, and a portion of the car-
boxyl terminus [S24,S29]. Downregulation requires a
YppØ motif in the cytoplasmic tail of the MHC class I
heavy chain: in HLA-A and HLA-B, this motif has the
sequence YSQA, [S24,S29] which would be expected to
give weak interaction with the µ1-adaptin chain of AP-1. It
is unclear whether this motif is involved in the normal
traffic of MHC molecules. One possibility is that the YSQA
motif is normally non-functional, and that Nef somehow
induces a conformational change in the MHC class I cyto-
plasmic tail that allows this motif to be used for traffic
[S24,S29]. A kinase or phosphatase, interacting with Nef
via the SH3 ligand domain, might conceivably mediate this
activation. Alternatively, Nef may cause the MHC mole-
cules to aggregate, increasing the avidity of binding of
clathrin-associated AP complexes to the YSQA motif.
The model that emerges from these studies is a complex
one: Nef must contain at least four functional regions
required for its effects on membrane traffic, one responsi-
ble for interacting with V-ATPase, the second containing
an AP-binding motif, the third providing a direct or indi-
rect interaction with CD4 and the fourth being required
for MHC class I downregulation. From our results and
those of Lu et al. [S26] it would appear that Nef requires
both the V-ATPase interaction domain and the AP-
binding motif to localize to coated pits and induce CD4
downregulation. These interactions may therefore offer an
attractive novel target for drug design.
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Supplementary material S3
Figure 1
Conserved dileucine motif in Nef proteins. (a) Alignment of the amino
acid sequence of HIV-1 NL4-3 Nef with the structural elements
defined by its high-resolution structure [S15,S16]. The structural
elements corresponding to the core, the amino-terminal disordered
arm and the carboxy-terminal disordered loop are indicated. The amino
acids located at the boundary between the core and the disordered
segments are shown. R71 replaces T71 in the HIV-1 NL4-3 Nef
protein used for its X-ray structural determination [S16]. (b) Alignment
of the amino acid sequences from the amino-terminal disordered arm
of representative Nef proteins of HIV-1, HIV-2 and SIV. Tyrosine-based
motifs of the type YppØ are boxed. The HIV strain used for its
functional identification is underlined. (c) Alignment of the amino acid
sequences from the carboxy-terminal disordered loop of Nef proteins
of HIV-1, HIV-2, and SIV. The conserved dileucine motif and the
glutamic acid are boxed. The HIV strains NA7 and NL4-3 used in this
paper are underlined.
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